Search Results By Date:
Showing 436 - 450 of 760 results
  • Bejaoui K, Rolak LA. (2010 March). What is the risk of permanent disability from a multiple sclerosis relapse? NEUROLOGY. 74(11):900-2.
    PubMed ID: 20231665
  • Ward MA, Greenwood TM, Kumar DR, Mazza JJ, Yale SH. (2010 March). Josef Brudzinski and Vladimir Mikhailovich Kernig: signs for diagnosing meningitis. Clinical Medicine & Research. 8(1):13-7.
    PubMed ID: 20305144
  • Mareedu RK, Abdalrahman IB, Dharmashankar KC, Granada JF, Chyou P, Sharma PP,...Vidaillet HJ [including Smith PN, Hayes JJ, Greenlee RT.] (2010 March). Atrial flutter versus atrial fibrillation in a general population: differences in comorbidities associated with their respective onset. Clinical Medicine & Research. 8(1):1-6.
    PubMed ID: 19920163
  • Go A, Fan D, Chang Y, Chan J, Lieu T, Magid D,...Singer D [including Schmelzer J.] (2010). Quality of Anticoagulation Management in Atrial Fibrillation and Venous Thromboembolism: The CVRN WAVE Study. CIRCULATION. 122(18 Suppl 3):A13870.
  • Yazigi N, Yale S, Glurich, I, Schmelzer, J, Burmester, J, Berg, R, Caldwell, M. (2010). Modeling Clearance of Warfarin - Preliminary Report. J Gen Intern Med. 25(Suppl 3):334.
  • Foley MR, Rokey R, Belfort MA. (2010). Cardiac Disease In: Belfort M, Saade G, Foley M, Phelan J, Dildy G. (Ed.), Critical Care Obstetrics (5th ed.). (pp. 256-82). Wiley-Blackwell;.
  • Anderson KP. (2010). Heart Block In: Bope ET, Rakel RE, Kellerman RD. (Ed.), Conn's Current Therapy. (pp. 327-30). W.B. Saunders.
  • Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D,...Rezkalla SH. (2009 December). Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome. AMERICAN HEART JOURNAL. 158(6):896-901.e3.
  • Anderson KP. (2009 October). Health status assessment tools: natural components of cardiac resynchronization therapy? Pacing Clin Electrophysiol. 32(10):1257-8.
    PubMed ID: 19732356
  • Gupta-Malhotra M, Gruber D, Abraham SS, Roman MJ, Zabriskie JB, Hudgins LC,...Cooper RS [including Okorie U.] (2009 Oct). Atherosclerosis in survivors of Kawasaki disease. J. Pediatr.. 155(4):572-7.
    PubMed ID: 19595365
  • LeBaron CW, Forghani B, Matter L, Reef SE, Beck CM, Bi D,...Sullivan BJ. (2009 September). Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine. J Infect Dis. 200(6):888-99.
    PubMed ID: 19659440
  • Greenlee RT, Chyou P, Sharma PP, Smith PN, Hayes JJ, Mareedu RK,...Vidaillet HJ. (2009 September). Recurrence and Mortality in Secondary Atrial Fibrillation: A Population-Based Study from the Marshfield Epidemiologic Study Area. European Congress of Epidemiology, Warsaw, Poland, 2009 European Jouranl of Epidemiology. 24(Supplement):55.
  • Johnson SK, Naidu RK, Ostopowicz RC, Kumar DR, Bhupathi S, Mazza JJ, Yale SH. (2009 September). Adolf Kussmaul: distinguished clinician and medical pioneer. Clinical Medicine & Research. 7(3):107-12.
    PubMed ID: 19805799
  • Yale SH, Schmelzer JR. (2009 September). Asthma Guidelines: The Product of Science and Politics. ANNALS OF FAMILY MEDICINE.
  • Oravecz-Wilson KL, Philips ST, Yilmaz OH, Ames HM, Li L, Crawford BD,...Ross TS [including Sitwala KViren.] (2009 August). Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorder. CANCER CELL. 16(2):137-8.
    PubMed ID: 19647224